Background/Purpose: Percutaneous coronary intervention (PCI) has been increasingly adopted for unprotected left main coronary artery (LMCA) disease. The aim of this study was to evaluate the predictors of long-term clinical outcomes in patients after elective stent implantation for unprotected LMCA disease. Methods: A total of 122 patients with medically refractory angina who received coronary stenting for unprotected LMCA disease between August 1997 and December 2008 were included. Results: During the follow-up period of 45 ± 35 months (range: 1-137 months), the incidence of repeated PCI and/or coronary artery bypass grafting (CABG), and cardiovascular and total mortality were 28% (34 patients), 20% (24 patients), and 25% (31 patients 
Unprotected left main coronary artery (LMCA) disease is considered to be a class II A or II B indication for percutaneous coronary intervention (PCI), according to current guidelines if coronary artery bypass grafting (CABG) is not a viable option. 1, 2 Several studies have revealed that PCI for unprotected LMCA disease can be considered in selected patients. [3] [4] [5] [6] [7] [8] Recently, drug-eluting stent (DES) placement has been recommended if PCI is undertaken in unprotected LMCA disease. [9] [10] [11] [12] [13] However, the predictors of long-term clinical outcomes in this patient population have not been well established. [9] [10] [11] [12] [13] [14] Therefore, the purpose of our study was to investigate the predictors of long-term clinical outcomes in patients after elective stent implantation for unprotected LMCA disease.
Methods

Study population
From August 1997 to December 2008, 136 patients with medically refractory angina received elective coronary stenting at our institute for unprotected LMCA disease with angiographic evidence of > 50% diameter stenosis. Follow-up was absent in 14 patients, thus a total of 122 patients were included. The decision for stent implantation instead of surgical revascularization was considered when one of these two conditions was present; those who presented as highly symptomatic but inoperable because of comorbidity or those who refused CABG with a preference for PCI. Informed consent forms on the treatment choice between LMCA stenting or CABG was obtained from all patients before the procedure.
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Stent implantation
All patients were treated with the percutaneous trans-femoral approach via an angiography sheath and the standard angioplasty technique. 3, 6 Each patient received intravenous heparin (100 U/kg), and, if necessary, an additional bolus of heparin was administered to maintain activated clotting time at > 5 minutes. Quantitative angiographic analysis was performed to demonstrate the stenosis in its most severe and non-foreshortened projection. With the use of a contrast-filled guiding catheter as the calibration standard, reference and lesion minimal lumen diameter were determined. Successful immediate outcome of stent implantation for LMCA disease was defined as < 30% residual stenosis. Myocardial infarction (MI) was diagnosed by a rise in the creatine kinase level to more than twice the upper normal limit, with an increased creatine kinase MB fraction. Post-stenting medications included aspirin (100 mg/day) and clopidogrel (75 mg/day). Therapy was continued for 3 months in patients who received a bare-metal stent (BMS) and 12 months in those who received a DES, and aspirin was continued indefinitely. The choice between BMS and DES was left to the patients' preference because our insurance system does not cover the fee for DES. Clinical follow-up was obtained by clinical visits, telephone conversation, and chart review.
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Predictors of long-term cardiovascular outcomes
The outcomes analyzed for follow-up were target vessel revascularization (TVR), cardiovascular death, all-cause mortality, and composite TVR/ total mortality. TVR was defined as any repeated revascularization (either PCI or CABG) to treat a luminal re-narrowing within the stent, or within 5-mm borders adjacent to the stent. Any death was considered cardiac unless proven otherwise. The analyzed variables included: age (≥ 65 years or < 65 years); sex; a history of prior MI or PCI; smoking; diabetes mellitus; hypertension; anemia (hemoglobin < 13 mg/dL in men, < 11 mg/dL in women); chronic renal insufficiency (serum creatinine ≥ 2 mg/dL); hypercholesterolemia (lowdensity lipoprotein ≥ 130 mg/dL); left ventricular ejection fraction (LVEF) (≥ 40% or < 40%); position of LMCA stenosis (proximal, middle or distal); stent size (≥ 4.0 mm or < 4.0 mm); and stent type (BMS or DES).
Statistical analysis
Continuous variables were shown as mean ± standard deviation, and categorical variables were presented as counts and percentages. Event-free survival at follow-up was evaluated according to the Kaplan-Meier method, and survival among groups was compared with the log-rank test.
Multivariate analysis was performed with a Cox regression model to determine the independent predictors of the long-term outcomes. Variables selected to be tested in the multivariate analysis were those with a p value < 0.1 in the univariate model. A p value < 0.05 was considered statistically significant, and confidence interval (CI) was 95%.
Results
Immediate and long-term outcomes of stent implantation
Basic clinical and angiographic characteristics of the 122 patients are shown in Patients with pure LMCA lesions, LMCA plus one-vessel disease, LMCA plus two-vessel disease, and LMCA plus three-vessel disease were 20% (24 patients), 24% (29 patients), 39% (48 patients), and 17% (21 patients), respectively. Ninety-eight patients (80%) received PCI in other coronary arteries at the time of LMCA stenting, in which right coronary artery stenting was performed in 47 patients, whereas PCI of three vessels in addition to LMCA stenting was achieved in 21 patients. Immediate success was achieved in all of the patients without major complications.
During a follow-up period of 45 ± 35 months (range: 1-137 months), 34 patients (28%) underwent repeated coronary intervention for recurrent angina; 19 (16%) received PCI, 12 (10%) CABG, and three (2%) both PCI and CABG for restenosis of LMCA. In the three patients who received both PCI and CABG, the LMCA stenosis was located in the distal portion, and simple crossover stenting was performed at the first time of LMCA stenting. All three patients received repeated PCI within 6 months because of LMCA restenosis and/or ostial side branch restenosis. Unfortunately, all three patients needed to receive CABG soon because of LMCA restenosis and/or new stenosis of other coronary arteries.
Thirty-one patients (25%) died: 24 (20%) with cardiovascular disease and seven (5%) with noncardiovascular disease. In the six deaths within 3 months after LMCA stenting, five were due to acute MI, and one of these had received a second PCI. The other patient died from congestive heart failure after CABG for unstable angina ( Table 2) . The Figure shows the Kaplan-Meier curve for freedom from TVR, cardiovascular death, total death, and composite TVR/total mortality at follow-up.
Predictors of repeated PCI and/or CABG
Univariate analysis revealed that young age (p = 0.003), lower LVEF (p = 0.08), small stent size (p = 0.01), and BMS use (p = 0.01) were related to repeated PCI and/or CABG ( 
Predictors of cardiovascular mortality
Univariate analysis revealed that anemia (p < 0.001), chronic renal insufficiency (p < 0.001), and lower LVEF (p < 0.001) were related to cardiovascular mortality (Table 3 ). Multivariate analysis showed that only lower LVEF could predict the presence of cardiovascular mortality (p = 0.003; HR: 4.25, 95% CI: 1.63-11.08).
Predictors of total mortality
Univariate analysis revealed that anemia (p < 0.001), chronic renal insufficiency (p < 0.001), lower LVEF (p < 0.001), and position of LMCA stenosis (p = 0.07) were associated with total mortality (Table 3 ). Multivariate analysis showed that only lower LVEF could predict the presence of total mortality (p = 0.002; HR: 3.95, 95% CI: 1.65-9.45).
Predictors of composite TVR/total mortality
Univariate analysis revealed that anemia (p = 0.02), chronic renal insufficiency (p = 0.099), lower LVEF (p < 0.001), and small stent size (p = 0.01) were associated with composite TVR/total mortality (Table 3 ). Multivariate analysis showed that lower LVEF (p = 0.001; HR: 0.31, 95% CI: 0.16-0.61) and small stent size (p = 0.01; HR: 5.95, 95% CI: 1.43-24.80) could predict composite TVR/total mortality.
Discussion
Major findings
The present study showed that young age and BMS use could predict repeated PCI and/or CABG in patients after stent implantation for unprotected LMCA disease. Only lower LEVF could predict both cardiovascular and total mortality.
Comparisons with previous studies
Previous studies have shown that in-hospital mortality is around 0-3% after stent implantation in patients with unprotected LMCA disease. [6] [7] [8] [9] [10] In the present study, none of the patients had inhospital mortality after stenting of unprotected LMCA stenosis. However, six of 24 cardiovascular deaths occurred within the first 3 months after stent implantation. This finding suggests that stent thrombosis plays an important role in early cardiovascular mortality. The present study suggests that PCI should only be considered in selected patients.
Predictors of repeated PCI and/or CABG
Price et al have reported that impaired renal function can predict TVR in patients who receive DES implantation for unprotected LMCA disease. 10 Previous studies have shown that the incidence of TVR after unprotected LMCA stenting was 17-31% in the BMS era and 2-14% in the DES era. [9] [10] [11] [15] [16] [17] [18] [19] The present study also showed that patients in the DES group had significantly lower rates of TVR than those in the BMS group. Cameron et al have demonstrated that young age and female sex can predict recurrent angina within 1 year of CABG for coronary artery disease. 20 Our previous study has shown that young age and female sex can predict repeated revascularization after unprotected LMCA stenting. 6 The present study found that BMS use and young age could predict repeated PCI and/or CABG after stent implantation for unprotected LMCA disease. Furthermore, some previous studies have found that maximal balloon inflation pressure correlates with occurrence of angiographic restenosis in patients after unprotected LMCA stenting. 9, 10 These findings suggest that small vessel size explains the higher incidence of restenosis after stent implantation for unprotected LMCA disease. The present study revealed that the patients who needed repeated PCI and/or CABG tended to have small stent size; however, the stent size was not a predictor of repeated PCI and/or CABG.
Predictors of cardiovascular mortality
Our previous study has shown that lower LVEF is associated with cardiovascular mortality after unprotected LMCA stenting. 6 Meliga et al have reported that lower LVEF, old age, shock, and EuroSCORE (European System for Cardiac Operative Risk Evaluation) were associated with cardiovascular mortality. 13 Tamburino et al have shown that lower LVEF, diabetes mellitus, and reference vessel diameter are predictive of cardiovascular mortality after stent implantation for unprotected LMCA disease. 8 The present study showed that only lower LVEF could predict cardiovascular mortality after coronary stenting for unprotected LMCA disease.
Predictors of total mortality
Price et al have reported that impaired renal function is the only predictor of total mortality. 10 Palmerini et al have shown that lower LVEF, acute coronary syndrome and peripheral vascular disease can predict total mortality after stent implantation for unprotected LMCA disease. 12 Tamburino et al have demonstrated that lower LVEF, diabetes mellitus, and EuroSCORE were predictors of total mortality. 8 The present study and our previous study have shown that lower LVEF but not impaired renal function could predict total mortality after stent implantation for unprotected LMCA disease.
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Predictors of composite TVR/total mortality
Valgimigli et al have revealed that reference vessel diameter is predictive of major adverse cardiovascular events (MACEs) after stent implantation for unprotected LMCA disease. 15 Price et al have reported that chronic renal insufficiency is an independent predictor of MACEs. 10 Furthermore, some studies have found that DES implantation could predict lower MACE rate in patients who are receiving unprotected LMCA stenting. 8, 9, 15 The present study showed that lower LVEF and small stent size, but not BMS implantation, could predict composite TVR/total mortality.
Limitations
First, the number of patients was small. Second, angiographic follow-up was only performed in patients with clinical presentation or non-invasive evaluation, which suggested the presence of myocardial ischemia, which led to possible underestimation of the restenosis rate of LMCA stenting. Third, patients were treated in a time frame in which evolution of devices (such as intravascular ultrasonography and DES) and operator experience might have had an impact on outcomes. Finally, because we did not routinely perform echocardiography or right heart catheterization in each patient, we could not provide EuroSCORE and Parsonnet score for the study populations. Also, SYNTAX score could not be provided because of the extended time period in this study when SYNTAX score was not available. Despite these limitations, long-term clinical outcomes following stent implantation for unprotected LMCA disease are still relatively acceptable.
In conclusion, the present study showed that young age and BMS implantation could predict repeated PCI and/or CABG in patients after stent implantation for unprotected LMCA disease. Only lower LVEF could predict both cardiovascular and total mortality. Lower LVEF and small stent size, but not BMS implantation, could predict composite TVR/total mortality.
